Chemotherapy Here to Stay-89241_slide_ppt.pdf

《Chemotherapy Here to Stay-89241_slide_ppt.pdf》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。

1、WhyChemotherapyisHeretoStayfortheTreatmentofLungCancers
PresentedByMarkKrisat2014ASCOAnnualMeetingChemotherapyisheretostayforlungcancers
Disclosures
PresentedByMarkKrisat2014ASCOAnnualMeetingChemotherapyisheretostayinlungcancers
Definit

2、ionPresentedByMarkKrisat2014ASCOAnnualMeetingChemotherapyisheretostayinlungcancers
IntroductionPresentedByMarkKrisat2014ASCOAnnualMeetingLCMC:FrequencyofOncogenicDriversPresentedByMarkKrisat2014ASCOAnnualMeetingSlide6PresentedByMarkKrisat2014ASCOAn

3、nualMeetingAfterNovelAgent
TimeonTherapy8monthsPresentedByMarkKrisat2014ASCOAnnualMeetingSlide8PresentedByMarkKrisat2014ASCOAnnualMeetingChemotherapyisheretostayinlungcancers
Cell-Cycle-TargetedAgentsforLungCancersPresentedByMarkKrisat2014ASCOA

4、nnualMeetingChemotherapyisheretostayinlungcancers
TimelineofCell-Cycle-TargetedChemotherapiesforLungCancersPresentedByMarkKrisat2014ASCOAnnualMeetingChemotherapyisheretostayforlungcancers
TruthsAboutChemotherapyforLungCancers(warning:somemaybei

5、nconvenient)PresentedByMarkKrisat2014ASCOAnnualMeetingEffectofNeoadjuvantChemotherapyonSurvivalofLungCancersPresentedByMarkKrisat2014ASCOAnnualMeetingChemotherapyisheretostayinlungcancers
NeoadjuvantTherapyImprovesSurvivalPresentedByMarkKrisat2014A

6、SCOAnnualMeetingMajorPathologicResponseasSurrogatePresentedByMarkKrisat2014ASCOAnnualMeetingNeoadjuvantSwitchTherapyGuidedByPETResponse
MethodtoAssessMajorPathologicResponseinResectionSpecimensAfterNeoadjuvantTherapyPresentedByMarkKrisat2014ASCOAnn

7、ualMeetingNEOSCAN:AphaseIItrialofneoadjuvantchemotherapyforresectablelungcancerswithaswitchtochemotherapyalternativein18F-FDGPETnon-respondersPresentedByMarkKrisat2014ASCOAnnualMeetingNeoadjuvantSwitchTherapyGuidedByPETResponse
NEOSCAN:TrialDesignP

8、resentedByMarkKrisat2014ASCOAnnualMeetingSlide18PresentedByMarkKrisat2014ASCOAnnualMeetingNeoadjuvant(NeoSphere)TrialinHER2PositiveBreastCancersPresentedByMarkKrisat2014ASCOAnnualMeetingNeoSphereResults
NeoadjuvantRegimensinBreastCa